A Phase 1 Dose-Escalation Study of Adding Venetoclax to a Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic Hematopoietic Cell Transplantation for Patients with High Risk Myeloid Malignancies
Year: 2019
Type: conference-abstract
Source: Blood
Authors: Jacqueline S Garcia, Haesook T. Kim, Jennifer Brock, Amy Han, Jeremy A. Ryan, Thelma Mashaka, Anthony G. Letai, R. Coleman Lindsley, Mahasweta Gooptu, Vincent T. Ho, John Koreth, Sarah Nikiforow, Rizwan Romee, Ilene Galinsky, Martha Wadleigh, David P. Steensma, Richard M. Stone, Robert J. Soiffer, Corey Cutler, Daniel J. DeAngelo, Joseph H. Antin
Institutions: Dana-Farber Cancer Institute, Harvard University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2983857459